Timothy Daley
Stock Analyst at Wells Fargo
(2.05)
# 2,976
Out of 5,163 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $40.60 | +9.51% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.66 | +329.18% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $85.57 | +11.02% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $33.75 | +113.33% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $111.51 | +30.03% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,173.74 | +10.76% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $286.57 | -0.55% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $187.32 | +31.86% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $155.46 | +76.89% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $263.80 | +2.35% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $9.09 | +208.03% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $14.99 | +133.49% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $464.37 | +11.98% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.34 | +2,544.73% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $114.20 | +62.00% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $75.12 | +13.15% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $164.72 | +33.56% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $98.33 | +123.74% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $7.93 | +253.09% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $199.70 | -29.89% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $50.85 | +76.99% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $40.60
Upside: +9.51%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.66
Upside: +329.18%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $85.57
Upside: +11.02%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $33.75
Upside: +113.33%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $111.51
Upside: +30.03%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,173.74
Upside: +10.76%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $286.57
Upside: -0.55%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $187.32
Upside: +31.86%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $155.46
Upside: +76.89%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $263.80
Upside: +2.35%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $9.09
Upside: +208.03%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $14.99
Upside: +133.49%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $464.37
Upside: +11.98%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.34
Upside: +2,544.73%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $114.20
Upside: +62.00%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $75.12
Upside: +13.15%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $164.72
Upside: +33.56%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $98.33
Upside: +123.74%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $7.93
Upside: +253.09%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $199.70
Upside: -29.89%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $50.85
Upside: +76.99%